Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Chambers

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
American Journal of Obstetrics & Gynecology MFM|May 16, 2021
Reported case numbers and variability in delivery route and volume by obstetrics and gynecology residents from 2003 to 2019Carrie Bennett, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology Reports|April 27, 2023
Gastritis as an immunotherapy-related toxicity in the treatment of endometrial cancer: A case reportNidhi Goel, Monica D Levine, Laura M Chambers, et al.
American Journal of Obstetrics and Gynecology|May 31, 2022
Is there a "low-risk" patient population in advanced epithelial ovarian cancer?: a critical analysisLaura M Chambers, David M O'Malley, Robert L Coleman, et al.
Gynecology & Obstetrics (Sunnyvale, Calif.)|December 20, 2021
The Overtreatment and Cost Effectiveness of Primary <i>versus</i> Secondary Maintenance Therapy with Poly-Adenosine Ribose Phosphate Inhibitors (PARPi) for Epithelial Ovarian Cancer (EOC)Peter G Rose, Meng Yao, Laura M Chambers, et al.
Gynecologic Oncology|June 6, 2020
Efficacy and toxicity of prolonged pegylated liposomal doxorubicin use in women with recurrent epithelial ovarian cancerLaura M Chambers, Adam Pendlebury, Peter G Rose, et al.
American Journal of Obstetrics and Gynecology|May 11, 2019
Does surgical platform impact recurrence and survival? A study of utilization of multiport, single-port, and robotic-assisted laparoscopy in endometrial cancer surgeryLaura M Chambers, Caitlin Carr, Lindsey Freeman, et al.
Plos One|April 30, 2020
Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancerLaura M Chambers, Emily Esakov, Chad Braley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
Evidence and best practices for trauma-informed care in gynecologic oncology patientsJessica Fulton, Haverly Snyder, Julia Chalif, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2020
Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinomaLaura M Chambers, Alyssa Herrmann, Chad M Michener, et al.
Journal of Minimally Invasive Gynecology|December 21, 2020
Meta-analysis of Laparoendoscopic Single-site and Vaginal Natural Orifice Transluminal Endoscopic Hysterectomy Compared with Multiport Hysterectomy: Real Benefits or Diminishing Returns?Chad M Michener, Erika Lampert, Meng Yao, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
American Journal of Obstetrics & Gynecology MFM|May 16, 2021
Reported case numbers and variability in delivery route and volume by obstetrics and gynecology residents from 2003 to 2019Carrie Bennett, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology Reports|April 27, 2023
Gastritis as an immunotherapy-related toxicity in the treatment of endometrial cancer: A case reportNidhi Goel, Monica D Levine, Laura M Chambers, et al.
American Journal of Obstetrics and Gynecology|May 31, 2022
Is there a "low-risk" patient population in advanced epithelial ovarian cancer?: a critical analysisLaura M Chambers, David M O'Malley, Robert L Coleman, et al.
Gynecology & Obstetrics (Sunnyvale, Calif.)|December 20, 2021
The Overtreatment and Cost Effectiveness of Primary <i>versus</i> Secondary Maintenance Therapy with Poly-Adenosine Ribose Phosphate Inhibitors (PARPi) for Epithelial Ovarian Cancer (EOC)Peter G Rose, Meng Yao, Laura M Chambers, et al.
Gynecologic Oncology|June 6, 2020
Efficacy and toxicity of prolonged pegylated liposomal doxorubicin use in women with recurrent epithelial ovarian cancerLaura M Chambers, Adam Pendlebury, Peter G Rose, et al.
American Journal of Obstetrics and Gynecology|May 11, 2019
Does surgical platform impact recurrence and survival? A study of utilization of multiport, single-port, and robotic-assisted laparoscopy in endometrial cancer surgeryLaura M Chambers, Caitlin Carr, Lindsey Freeman, et al.
Plos One|April 30, 2020
Use of Transabdominal Ultrasound for the detection of intra-peritoneal tumor engraftment and growth in mouse xenografts of epithelial ovarian cancerLaura M Chambers, Emily Esakov, Chad Braley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
Evidence and best practices for trauma-informed care in gynecologic oncology patientsJessica Fulton, Haverly Snyder, Julia Chalif, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2020
Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinomaLaura M Chambers, Alyssa Herrmann, Chad M Michener, et al.
Journal of Minimally Invasive Gynecology|December 21, 2020
Meta-analysis of Laparoendoscopic Single-site and Vaginal Natural Orifice Transluminal Endoscopic Hysterectomy Compared with Multiport Hysterectomy: Real Benefits or Diminishing Returns?Chad M Michener, Erika Lampert, Meng Yao, et al.
Pageof 8